Shumei Man1,2, Xin Zhao3, Ken Uchino2, M Shazam Hussain2, Eric E Smith4, Deepak L Bhatt5, Ying Xian3,6, Lee H Schwamm7, Shreyansh Shah6, Yosef Khan8, Gregg C Fonarow9. 1. Department of Neurology, Miami Valley Hospital, Wright State University Boonshoft School of Medicine, Dayton, OH (S.M.). 2. Cerebrovascular Center, Neurological Institute, Cleveland Clinic, OH (S.M., K.U., M.S.H.). 3. Duke Clinical Research Center, Durham, NC (X.Z., Y.X.). 4. Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada (E.E.S.). 5. Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA (D.L.B.). 6. Department of Neurology, Duke University Medical Center, Duke University School of Medicine, Durham, NC (S.S., Y.X.). 7. Division of Neurology, Massachusetts General Hospital, Boston (L.H.S.). 8. Department of Quality and HIT, National Center, American Heart Association, Dallas, TX (Y.K.). 9. Division of Cardiology, University of California, Los Angeles (G.C.F.). gfonarow@mednet.ucla.edu.
Abstract
BACKGROUND: To improve stroke care, the Brain Attack Coalition recommended establishing primary stroke center (PSC) and comprehensive stroke center (CSC) certification. This study aimed to compare ischemic stroke care and in-hospital outcomes between CSCs and PSCs. METHODS AND RESULTS: We analyzed patients with acute ischemic stroke who were hospitalized at stroke centers participating in Get With The Guidelines-Stroke from 2013 to 2015. Multivariable logistic regression models were generated to examine the association between stroke center certification (CSC versus PSC) and performances and outcomes. This study included 722 941 patients who were admitted to 134 CSCs and 1047 PSCs. Both CSCs and PSCs had good conformity to 7 performance measures and the summary defect-free care measure. Among emergency department admissions, CSCs had higher intravenous tPA (tissue-type plasminogen activator) and endovascular thrombectomy rates than PSCs (14.3% versus 10.3%, 4.1% versus 1.0%, respectively). Door to intravenous tPA time was shorter at CSCs (median, 52 versus 61 minutes; adjusted risk ratio, 0.92; 95% confidence interval, 0.89-0.95). More patients at CSCs had door to intravenous tPA time ≤60 minutes (79.7% versus 65.1%; adjusted odds ratio, 1.48; 95% confidence interval, 1.25-1.75). For transferred patients, CSCs and PSCs had comparable overall performance in defect-free care, except higher endovascular thrombectomy therapy rates. The overall in-hospital mortality was higher at CSCs in both emergency department admissions (4.6% versus 3.8%; adjusted odds ratio, 1.14; 95% confidence interval, 1.01-1.29) and transferred patients (7.7% versus 6.8%; adjusted odds ratio, 1.17; 95% confidence interval, 1.05-1.32). In-hospital outcomes were comparable between CSCs and PSCs in patients who received intravenous tPA or endovascular thrombectomy. CONCLUSIONS: CSCs and PSCs achieved similar overall care quality for patients with acute ischemic stroke. CSCs exceeded PSCs in timely acute reperfusion therapy for emergency department admissions, whereas PSCs had lower risk-adjusted in-hospital mortality. This information may be important for acute stroke triage and targeted quality improvement.
BACKGROUND: To improve stroke care, the Brain Attack Coalition recommended establishing primary stroke center (PSC) and comprehensive stroke center (CSC) certification. This study aimed to compare ischemic stroke care and in-hospital outcomes between CSCs and PSCs. METHODS AND RESULTS: We analyzed patients with acute ischemic stroke who were hospitalized at stroke centers participating in Get With The Guidelines-Stroke from 2013 to 2015. Multivariable logistic regression models were generated to examine the association between stroke center certification (CSC versus PSC) and performances and outcomes. This study included 722 941 patients who were admitted to 134 CSCs and 1047 PSCs. Both CSCs and PSCs had good conformity to 7 performance measures and the summary defect-free care measure. Among emergency department admissions, CSCs had higher intravenous tPA (tissue-type plasminogen activator) and endovascular thrombectomy rates than PSCs (14.3% versus 10.3%, 4.1% versus 1.0%, respectively). Door to intravenous tPA time was shorter at CSCs (median, 52 versus 61 minutes; adjusted risk ratio, 0.92; 95% confidence interval, 0.89-0.95). More patients at CSCs had door to intravenous tPA time ≤60 minutes (79.7% versus 65.1%; adjusted odds ratio, 1.48; 95% confidence interval, 1.25-1.75). For transferred patients, CSCs and PSCs had comparable overall performance in defect-free care, except higher endovascular thrombectomy therapy rates. The overall in-hospital mortality was higher at CSCs in both emergency department admissions (4.6% versus 3.8%; adjusted odds ratio, 1.14; 95% confidence interval, 1.01-1.29) and transferred patients (7.7% versus 6.8%; adjusted odds ratio, 1.17; 95% confidence interval, 1.05-1.32). In-hospital outcomes were comparable between CSCs and PSCs in patients who received intravenous tPA or endovascular thrombectomy. CONCLUSIONS: CSCs and PSCs achieved similar overall care quality for patients with acute ischemic stroke. CSCs exceeded PSCs in timely acute reperfusion therapy for emergency department admissions, whereas PSCs had lower risk-adjusted in-hospital mortality. This information may be important for acute stroke triage and targeted quality improvement.
Authors: Michael P Thompson; Zhehui Luo; Joseph Gardiner; James F Burke; Adrienne Nickles; Mathew J Reeves Journal: Circ Cardiovasc Qual Outcomes Date: 2016-05-10
Authors: Maxim Mokin; Rishi Gupta; Waldo R Guerrero; David Z Rose; William S Burgin; Sananthan Sivakanthan Journal: J Neurointerv Surg Date: 2016-04-22 Impact factor: 5.836
Authors: Shumei Man; Margueritte Cox; Puja Patel; Eric E Smith; Mathew J Reeves; Jeffrey L Saver; Deepak L Bhatt; Ying Xian; Lee H Schwamm; Gregg C Fonarow Journal: Stroke Date: 2016-12-22 Impact factor: 7.914
Authors: Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Hester F Lingsma; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama à Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; Willem Jan J van Rooij; Jan S P van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Aad van der Lugt; Robert J van Oostenbrugge; Charles B L M Majoie; Diederik W J Dippel Journal: N Engl J Med Date: 2014-12-17 Impact factor: 91.245
Authors: Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni Journal: N Engl J Med Date: 2008-09-25 Impact factor: 91.245
Authors: E Bernd Ringelstein; Angel Chamorro; Markku Kaste; Peter Langhorne; Didier Leys; Philippe Lyrer; Vincent Thijs; Lars Thomassen; Danilo Toni Journal: Stroke Date: 2013-01-29 Impact factor: 7.914
Authors: Eric E Smith; Jeffrey L Saver; Margueritte Cox; Li Liang; Roland Matsouaka; Ying Xian; Deepak L Bhatt; Gregg C Fonarow; Lee H Schwamm Journal: Circulation Date: 2017-10-05 Impact factor: 29.690
Authors: David C Lauzier; Maria M Galardi; Kristin P Guilliams; Manu S Goyal; Catherine Amlie-Lefond; Danial K Hallam; Akash P Kansagra Journal: Stroke Date: 2021-03-11 Impact factor: 7.914
Authors: Julie Adhya; Charles Li; Laura Eisenmenger; Russell Cerejo; Ashis Tayal; Michael Goldberg; Warren Chang Journal: Neuroradiol J Date: 2021-04-28
Authors: Mark Padgham; Geoff Boeing; David Cooley; Nicholas Tierney; Michael Sumner; Thanh G Phan; Richard Beare Journal: Front Neurol Date: 2019-08-07 Impact factor: 4.003
Authors: D M Bravata; L J Myers; B Homoya; E J Miech; N A Rattray; A J Perkins; Y Zhang; J Ferguson; J Myers; A J Cheatham; L Murphy; B Giacherio; M Kumar; E Cheng; D A Levine; J J Sico; M J Ward; T M Damush Journal: BMC Neurol Date: 2019-11-20 Impact factor: 2.474
Authors: Hong-Kyun Park; Seong-Eun Kim; Yong-Jin Cho; Jun Yup Kim; Hyunji Oh; Beom Joon Kim; Jihoon Kang; Keon-Joo Lee; Min Uk Jang; Jong-Moo Park; Kwang-Yeol Park; Kyung Bok Lee; Soo Joo Lee; Ji Sung Lee; Juneyoung Lee; Ki Hwa Yang; Ah Rum Choi; Mi Yeon Kang; Eric E Smith; Philip B Gorelick; Hee-Joon Bae Journal: Eur Stroke J Date: 2019-05-24
Authors: Esmee Venema; James F Burke; Bob Roozenbeek; Jason Nelson; Hester F Lingsma; Diederik W J Dippel; David M Kent Journal: Stroke Date: 2020-10-07 Impact factor: 7.914